These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22204435)

  • 1. Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences.
    Mozaffari S; Abdollahi M
    Curr Pharm Des; 2011 Dec; 17(38):4372-8. PubMed ID: 22204435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and inflammatory bowel disease: From basic mechanisms to clinical application.
    Vaghari-Tabari M; Moein S; Alipourian A; Qujeq D; Malakoti F; Alemi F; Yousefi B; Khazaie S
    Biochimie; 2023 Jun; 209():20-36. PubMed ID: 36535545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of melatonin in combined treatment for inflammatory bowel diseases].
    Rakhimova OIu
    Ter Arkh; 2010; 82(12):64-8. PubMed ID: 21516743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of nutraceutical compounds in inflammatory bowel disease.
    Larussa T; Imeneo M; Luzza F
    World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer.
    Jurjus A; El Masri J; Ghazi M; El Ayoubi LM; Soueid L; Gerges Geagea A; Jurjus R
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.
    Farzaei MH; Bahramsoltani R; Abdolghaffari AH; Sodagari HR; Esfahani SA; Rezaei N
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):745-58. PubMed ID: 26799847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular diseases: protective effects of melatonin.
    Tengattini S; Reiter RJ; Tan DX; Terron MP; Rodella LF; Rezzani R
    J Pineal Res; 2008 Jan; 44(1):16-25. PubMed ID: 18078444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin.
    Gitto E; Pellegrino S; Gitto P; Barberi I; Reiter RJ
    J Pineal Res; 2009 Mar; 46(2):128-39. PubMed ID: 19054296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications.
    Gross V; Arndt H; Andus T; Palitzsch KD; Schölmerich J
    Hepatogastroenterology; 1994 Aug; 41(4):320-7. PubMed ID: 7959565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: from basic research to cancer treatment clinics.
    Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
    J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of melatonin therapy in irritable bowel syndrome: a systematic review.
    Mozaffari S; Rahimi R; Abdollahi M
    Curr Pharm Des; 2010; 16(33):3646-55. PubMed ID: 21128901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian rhythm and inflammatory bowel disease].
    Takagi T; Inada Y; Naito Y
    Nihon Rinsho; 2013 Dec; 71(12):2165-70. PubMed ID: 24437273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin, autophagy and intestinal bowel disease.
    Talero E; Garcia-Maurino S; Motilva V
    Curr Pharm Des; 2014; 20(30):4816-27. PubMed ID: 24251670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Andoh A
    Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.
    Ghattamaneni NKR; Panchal SK; Brown L
    Pharmacol Res; 2018 Jun; 132():99-107. PubMed ID: 29680446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of the clinical utilization of melatonin.
    Bubenik GA; Blask DE; Brown GM; Maestroni GJ; Pang SF; Reiter RJ; Viswanathan M; Zisapel N
    Biol Signals Recept; 1998; 7(4):195-219. PubMed ID: 9730580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin.
    Motilva V; García-Mauriño S; Talero E; Illanes M
    J Pineal Res; 2011 Aug; 51(1):44-60. PubMed ID: 21752096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questionable benefit of melatonin for antioxidant pharmacologic therapy.
    Wölfler A; Abuja PM; Linkesch W; Schauenstein K; Liebmann PM
    J Clin Oncol; 2002 Oct; 20(19):4127-8; author reply 4128-9. PubMed ID: 12351615
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of melatonin and hyaluronate/carboxymethylcellulose membrane in preventing adhesion reformation following adhesiolysis in a rat uterine model.
    Attar R; Yildirim G; Kumbak B; Ficicioglu C; Demirbag S; Yesildaglar N
    J Obstet Gynaecol Res; 2011 Feb; 37(2):125-31. PubMed ID: 21159036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of melatonin after night-shift work: efficacy and neuropsychologic effects.
    Wright SW; Lawrence LM; Wrenn KD; Haynes ML; Welch LW; Schlack HM
    Ann Emerg Med; 1998 Sep; 32(3 Pt 1):334-40. PubMed ID: 9737496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.